clinical trial · NCT05361707
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Autism Spectrum DisorderSleep DisorderNeurological DisorderSleep DisturbanceTasimelteon Oral Capsule, Tasimelteon Liquid Suspension
brief summary
This is a multicenter, open-label study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon in treating sleep disturbances in pediatric and adult participants with ASD.
started
Jul 28, 2021
primary completion
Jul 1, 2025
completion
Jul 1, 2025
last updated
Mar 21, 2024
official title
A Study to Evaluate the Efficacy and Safety of Tasimelteon in Treating Sleep Disturbances in Individuals With Autism Spectrum Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol